Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 20

Showing 20 citing articles:

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Jeffrey A. Klomp, Jennifer E. Klomp, Clint A. Stalnecker, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 30
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1614-1629.e5
Closed Access | Times Cited: 14
Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2329-2329
Open Access | Times Cited: 5
KRAS Oncoprotein Signaling in Cancer
Piro Lito
New England Journal of Medicine (2025) Vol. 392, Iss. 3, pp. 296-298
Closed Access
Targeting MXD1 sensitises pancreatic cancer to trametinib
Shaoping Zhang, Shuang Deng, Ji Liu, et al.
Gut (2025), pp. gutjnl-333408
Closed Access
Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells
Chuan Wang, Ya-Chin Hou, Yi‐Kai Hong, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
Cancer hotspot mutations rewire ERK2 specificity by selective exclusion of docking interactions
Jaylissa Torres Robles, Amy L. Stiegler, Titus J. Boggon, et al.
Journal of Biological Chemistry (2025), pp. 108348-108348
Open Access
Lanthanide-bimetallic organic frameworks: from mechanism and sensors design to ratiometric fluorescent applications
Jialing Zhou, Xiao Hu, Chen Liu, et al.
Coordination Chemistry Reviews (2025) Vol. 534, pp. 216574-216574
Closed Access
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
ERK synchronizes embryonic cleavages in Drosophila
Liu Yang, Audrey Zhu, Javed M Aman, et al.
Developmental Cell (2024) Vol. 59, Iss. 23, pp. 3061-3071.e6
Closed Access | Times Cited: 2
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity
Nicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression
Sarah E. Graham, Mariia Dmitrieva, Débora B. Vendramini‐Costa, et al.
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 801-816
Closed Access | Times Cited: 1
Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen and Identifies Co-Treatment Strategies in Estrogen Receptor Positive Breast Cancer
Rasha T. Kakati, Austin A. Whitman, Santiago Haase, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Reporter-based screening identifies RAS-RAF stabilizing mutations as drivers of resistance to broad-spectrum RAS inhibition in colorectal cancer
Oleksandra Aust, Eric Blanc, Mareen Lüthen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The mTOR pathway controls phosphorylation of BRAF at T401
Daniel Christen, Manuel Lauinger, Melanie Brunner, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Special Issue: MAPK Signaling Cascades in Human Health and Diseases
Rony Seger
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11226-11226
Open Access
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway
Runhui Lu, Ying Zhang, Ran Chen, et al.
Neoplasia (2024) Vol. 59, pp. 101082-101082
Closed Access
ERK-dependent protein phosphorylation in KRAS-mutant cancer: a mix of the expected and surprising
Kevin Huang, Yubao Wang, Thomas M. Roberts
Trends in Biochemical Sciences (2024)
Closed Access
Quantitative MRI Measurements Capture Pancreatic Cancer and Stroma Reactions to New KRAS Inhibitor
Mamta Gupta, Hoon Choi, Samantha B. Kemp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top